Published in Clin Infect Dis on January 15, 2008
P. Knowlesi Trial of Artemether-lumefantrine vs Chloroquine (CAN KNOW) | NCT02001012
Acquired immunity to malaria. Clin Microbiol Rev (2009) 6.24
New medicines to improve control and contribute to the eradication of malaria. Nat Rev Drug Discov (2009) 4.00
A research agenda for malaria eradication: drugs. PLoS Med (2011) 3.90
Knowlesi malaria: newly emergent and of public health importance? Trends Parasitol (2008) 3.66
Naturally acquired human Plasmodium knowlesi infection, Singapore. Emerg Infect Dis (2008) 3.63
Multiplexed real-time PCR assay for discrimination of Plasmodium species with improved sensitivity for mixed infections. J Clin Microbiol (2009) 3.62
Malaria in Brazil: an overview. Malar J (2010) 3.57
Human Infections with Plasmodium knowlesi, the Philippines. Emerg Infect Dis (2008) 3.55
A research agenda for malaria eradication: vaccines. PLoS Med (2011) 3.33
The genome of the simian and human malaria parasite Plasmodium knowlesi. Nature (2008) 3.02
Clinical and laboratory features of human Plasmodium knowlesi infection. Clin Infect Dis (2009) 2.92
Spurious amplification of a Plasmodium vivax small-subunit RNA gene by use of primers currently used to detect P. knowlesi. J Clin Microbiol (2009) 2.85
Plasmodium knowlesi: the fifth human malaria parasite. Clin Infect Dis (2008) 2.76
The origin of malignant malaria. Proc Natl Acad Sci U S A (2009) 2.67
Erythrocyte binding protein PfRH5 polymorphisms determine species-specific pathways of Plasmodium falciparum invasion. Cell Host Microbe (2008) 2.66
Plasmodium knowlesi in humans, macaques and mosquitoes in peninsular Malaysia. Parasit Vectors (2008) 2.62
On the diversity of malaria parasites in African apes and the origin of Plasmodium falciparum from Bonobos. PLoS Pathog (2010) 2.60
Plasmodium knowlesi: reservoir hosts and tracking the emergence in humans and macaques. PLoS Pathog (2011) 2.45
Monkey malaria in a European traveler returning from Malaysia. Emerg Infect Dis (2008) 2.32
Swedish traveller with Plasmodium knowlesi malaria after visiting Malaysian Borneo. Malar J (2009) 2.18
Human Plasmodium knowlesi infections in young children in central Vietnam. Malar J (2009) 2.13
Severe Plasmodium knowlesi malaria in a tertiary care hospital, Sabah, Malaysia. Emerg Infect Dis (2011) 2.11
Human infections and detection of Plasmodium knowlesi. Clin Microbiol Rev (2013) 2.05
Real-time fluorescence loop mediated isothermal amplification for the diagnosis of malaria. PLoS One (2010) 2.02
Morphological features and differential counts of Plasmodium knowlesi parasites in naturally acquired human infections. Malar J (2009) 1.97
Malaria diagnosis: a brief review. Korean J Parasitol (2009) 1.86
Population genetics of malaria resistance in humans. Heredity (Edinb) (2011) 1.85
Severe malaria - a case of fatal Plasmodium knowlesi infection with post-mortem findings: a case report. Malar J (2010) 1.72
Increasing incidence of Plasmodium knowlesi malaria following control of P. falciparum and P. vivax Malaria in Sabah, Malaysia. PLoS Negl Trop Dis (2013) 1.68
Limitations of microscopy to differentiate Plasmodium species in a region co-endemic for Plasmodium falciparum, Plasmodium vivax and Plasmodium knowlesi. Malar J (2013) 1.66
Use of malaria rapid diagnostic test to identify Plasmodium knowlesi infection. Emerg Infect Dis (2008) 1.66
Plasmodium knowlesi in human, Indonesian Borneo. Emerg Infect Dis (2010) 1.63
Malaria distribution, prevalence, drug resistance and control in Indonesia. Adv Parasitol (2011) 1.61
Bionomics of Anopheles latens in Kapit, Sarawak, Malaysian Borneo in relation to the transmission of zoonotic simian malaria parasite Plasmodium knowlesi. Malar J (2008) 1.61
A TaqMan real-time PCR assay for the detection and quantitation of Plasmodium knowlesi. Malar J (2010) 1.57
Artesunate-mefloquine versus chloroquine for treatment of uncomplicated Plasmodium knowlesi malaria in Malaysia (ACT KNOW): an open-label, randomised controlled trial. Lancet Infect Dis (2015) 1.54
A fresh look at the origin of Plasmodium falciparum, the most malignant malaria agent. PLoS Pathog (2011) 1.54
Co-infections with Plasmodium knowlesi and other malaria parasites, Myanmar. Emerg Infect Dis (2010) 1.53
Deaths due to Plasmodium knowlesi malaria in Sabah, Malaysia: association with reporting as Plasmodium malariae and delayed parenteral artesunate. Malar J (2012) 1.47
High proportion of knowlesi malaria in recent malaria cases in Malaysia. Malar J (2014) 1.47
History of the discovery of the malaria parasites and their vectors. Parasit Vectors (2010) 1.44
Plasmodium knowlesi from archival blood films: further evidence that human infections are widely distributed and not newly emergent in Malaysian Borneo. Int J Parasitol (2009) 1.43
Plasmodium knowlesi malaria in children. Emerg Infect Dis (2011) 1.42
Incidence of malaria in the interior division of sabah, malaysian borneo, based on nested PCR. J Parasitol Res (2011) 1.42
Vector-borne infections. Emerg Infect Dis (2011) 1.41
Immune mechanisms in malaria: new insights in vaccine development. Nat Med (2013) 1.40
Epidemiology of Plasmodium knowlesi malaria in north-east Sabah, Malaysia: family clusters and wide age distribution. Malar J (2012) 1.40
Malaria in Brazil: what happens outside the Amazonian endemic region. Mem Inst Oswaldo Cruz (2014) 1.39
The impact of malaria parasitism: from corpuscles to communities. J Clin Invest (2009) 1.37
Plasmodium knowlesi Malaria in humans and macaques, Thailand. Emerg Infect Dis (2011) 1.35
Human Plasmodium knowlesi infection detected by rapid diagnostic tests for malaria. Emerg Infect Dis (2009) 1.35
Giemsa-stained thick blood films as a source of DNA for Plasmodium species-specific real-time PCR. Malar J (2010) 1.32
Indigenous Plasmodium ovale malaria in Bangladesh. Am J Trop Med Hyg (2010) 1.30
Meta-analysis of immune epitope data for all Plasmodia: overview and applications for malarial immunobiology and vaccine-related issues. Parasite Immunol (2009) 1.30
Clinical and parasitological response to oral chloroquine and primaquine in uncomplicated human Plasmodium knowlesi infections. Malar J (2010) 1.29
Evaluation of a loop-mediated isothermal amplification method as a tool for diagnosis of infection by the zoonotic simian malaria parasite Plasmodium knowlesi. J Clin Microbiol (2010) 1.25
Changing epidemiology of malaria in Sabah, Malaysia: increasing incidence of Plasmodium knowlesi. Malar J (2014) 1.24
Adaptation of the genetically tractable malaria pathogen Plasmodium knowlesi to continuous culture in human erythrocytes. Proc Natl Acad Sci U S A (2012) 1.24
Expansion of host cellular niche can drive adaptation of a zoonotic malaria parasite to humans. Nat Commun (2013) 1.20
Imported Plasmodium knowlesi malaria in a French tourist returning from Thailand. Am J Trop Med Hyg (2011) 1.20
Molecular epidemiological investigation of Plasmodium knowlesi in humans and macaques in Singapore. Vector Borne Zoonotic Dis (2010) 1.15
Evaluation of the sensitivity of a pLDH-based and an aldolase-based rapid diagnostic test for diagnosis of uncomplicated and severe malaria caused by PCR-confirmed Plasmodium knowlesi, Plasmodium falciparum, and Plasmodium vivax. J Clin Microbiol (2013) 1.11
A new single-step PCR assay for the detection of the zoonotic malaria parasite Plasmodium knowlesi. PLoS One (2012) 1.11
Laboratory markers of disease severity in Plasmodium knowlesi infection: a case control study. Malar J (2012) 1.10
Phosphodiesterase inhibitors as a new generation of antiprotozoan drugs: exploiting the benefit of enzymes that are highly conserved between host and parasite. Future Med Chem (2011) 1.10
Defining the geographical range of the Plasmodium knowlesi reservoir. PLoS Negl Trop Dis (2014) 1.10
Hexaplex PCR detection system for identification of five human Plasmodium species with an internal control. J Clin Microbiol (2012) 1.07
Entomologic investigation of Plasmodium knowlesi vectors in Kuala Lipis, Pahang, Malaysia. Malar J (2012) 1.07
Genome sequences reveal divergence times of malaria parasite lineages. Parasitology (2010) 1.06
Admixture in Humans of Two Divergent Plasmodium knowlesi Populations Associated with Different Macaque Host Species. PLoS Pathog (2015) 1.06
Increased detection of Plasmodium knowlesi in Sandakan division, Sabah as revealed by PlasmoNex™. Malar J (2013) 1.05
The fragmented mitochondrial ribosomal RNAs of Plasmodium falciparum. PLoS One (2012) 1.04
Plasmodium knowlesi and Wuchereria bancrofti: Their Vectors and Challenges for the Future. Front Physiol (2012) 1.04
Regulation of CD8+ T cell responses to infection with parasitic protozoa. Exp Parasitol (2010) 1.04
Modelling knowlesi malaria transmission in humans: vector preference and host competence. Malar J (2010) 1.03
Population genomic structure and adaptation in the zoonotic malaria parasite Plasmodium knowlesi. Proc Natl Acad Sci U S A (2015) 1.01
Patterns of co-speciation and host switching in primate malaria parasites. Malar J (2009) 1.01
Susceptibility of human Plasmodium knowlesi infections to anti-malarials. Malar J (2013) 1.01
Vaccination with Plasmodium knowlesi AMA1 formulated in the novel adjuvant co-vaccine HT™ protects against blood-stage challenge in rhesus macaques. PLoS One (2011) 1.01
Sterile protection against Plasmodium knowlesi in rhesus monkeys from a malaria vaccine: comparison of heterologous prime boost strategies. PLoS One (2009) 1.01
The reticulocyte binding-like proteins of P. knowlesi locate to the micronemes of merozoites and define two new members of this invasion ligand family. Mol Biochem Parasitol (2009) 1.00
Isolation and characterization of the MSP1 genes from Plasmodium malariae and Plasmodium ovale. Am J Trop Med Hyg (2010) 0.99
Genetic variation among Plasmodium vivax isolates adapted to non-human primates and the implication for vaccine development. Am J Trop Med Hyg (2009) 0.99
Plasmodium falciparum-like parasites infecting wild apes in southern Cameroon do not represent a recurrent source of human malaria. Proc Natl Acad Sci U S A (2013) 0.98
Plasmodium knowlesi genome sequences from clinical isolates reveal extensive genomic dimorphism. PLoS One (2015) 0.98
Disease progression in Plasmodium knowlesi malaria is linked to variation in invasion gene family members. PLoS Negl Trop Dis (2014) 0.96
Evaluation of three rapid diagnostic tests for the detection of human infections with Plasmodium knowlesi. Malar J (2014) 0.95
Combining parasite lactate dehydrogenase-based and histidine-rich protein 2-based rapid tests to improve specificity for diagnosis of malaria Due to Plasmodium knowlesi and other Plasmodium species in Sabah, Malaysia. J Clin Microbiol (2014) 0.95
Structural and metabolic specificity of methylthiocoformycin for malarial adenosine deaminases. Biochemistry (2009) 0.95
Hyperparasitaemic human Plasmodium knowlesi infection with atypical morphology in peninsular Malaysia. Malar J (2013) 0.95
Development of potent and selective Plasmodium falciparum calcium-dependent protein kinase 4 (PfCDPK4) inhibitors that block the transmission of malaria to mosquitoes. Eur J Med Chem (2014) 0.95
Efficacy and safety of artemisinin combination therapy (ACT) for non-falciparum malaria: a systematic review. Malar J (2014) 0.95
Zoonotic malaria - global overview and research and policy needs. Front Public Health (2014) 0.94
Factors that are associated with the risk of acquiring Plasmodium knowlesi malaria in Sabah, Malaysia: a case-control study protocol. BMJ Open (2014) 0.94
Molecular-based assay for simultaneous detection of four Plasmodium spp. and Wuchereria bancrofti infections. Am J Trop Med Hyg (2010) 0.94
Co-infection and cross-species transmission of divergent Hepatocystis lineages in a wild African primate community. Int J Parasitol (2013) 0.93
Malaria-induced splenic infarction. Am J Trop Med Hyg (2014) 0.93
Crystal structure of arginase from Plasmodium falciparum and implications for L-arginine depletion in malarial infection . Biochemistry (2010) 0.92
Crystal structure of GAP50, the anchor of the invasion machinery in the inner membrane complex of Plasmodium falciparum. J Struct Biol (2012) 0.92
Seasonal and Spatial Dynamics of the Primary Vector of Plasmodium knowlesi within a Major Transmission Focus in Sabah, Malaysia. PLoS Negl Trop Dis (2015) 0.91
Containing pandemic influenza at the source. Science (2005) 23.95
Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg (2000) 22.12
A large focus of naturally acquired Plasmodium knowlesi infections in human beings. Lancet (2004) 12.21
A NATURALLY ACQUITED QUOTIDIAN-TYPE MALARIA IN MAN TRANSFERABLE TO MONKEYS. Science (1965) 6.49
Naturally acquired Plasmodium knowlesi malaria in human, Thailand. Emerg Infect Dis (2004) 5.58
[Human natural infection of Plasmodium knowlesi]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi (2006) 3.99
Natural transmission of Plasmodium knowlesi to humans by Anopheles latens in Sarawak, Malaysia. Trans R Soc Trop Med Hyg (2006) 2.94
Experimental mosquito-transmission of Plasmodium knowlesi to man and monkey. Am J Trop Med Hyg (1968) 2.89
Emerging infectious diseases: a 10-year perspective from the National Institute of Allergy and Infectious Diseases. Emerg Infect Dis (2005) 2.30
Increased sensitivity of malaria detection by nested polymerase chain reaction using simple sampling and DNA extraction. Int J Parasitol (1997) 1.83
Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future. Epidemiology (2005) 1.75
Experimental infection of the olive baboon (Paplio anubis) with Plasmodium knowlesi: severe disease accompanied by cerebral involvement. Am J Trop Med Hyg (2003) 1.65
Studies on the transmission of simian malarias. II. Transmission of the H strain of Plasmodium knowlesi by Anopheles balabacensis balabacensis. J Parasitol (1967) 1.63
Controlling emerging infectious diseases like SARS. Math Biosci (2005) 1.52
Nipah virus: an emergent paramyxovirus causing severe encephalitis in humans. J Neurovirol (2005) 1.52
Antimalarial drugs and glucose metabolism. Br J Clin Pharmacol (1997) 1.47
A large focus of naturally acquired Plasmodium knowlesi infections in human beings. Lancet (2004) 12.21
Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis. Lancet (2008) 9.05
Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia. Nat Genet (2013) 5.22
A trial of combination antimalarial therapies in children from Papua New Guinea. N Engl J Med (2008) 4.77
Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing. Nature (2012) 4.37
Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat Genet (2009) 4.30
Knowlesi malaria: newly emergent and of public health importance? Trends Parasitol (2008) 3.66
Human Infections with Plasmodium knowlesi, the Philippines. Emerg Infect Dis (2008) 3.55
Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria. Infect Immun (2008) 3.51
Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria. Vaccine (2004) 3.51
Population pharmacokinetics of piperaquine in adults and children with uncomplicated falciparum or vivax malaria. Br J Clin Pharmacol (2004) 3.48
Effect of two different house screening interventions on exposure to malaria vectors and on anaemia in children in The Gambia: a randomised controlled trial. Lancet (2009) 3.45
Efficacy and safety of dihydroartemisinin-piperaquine (Artekin) in Cambodian children and adults with uncomplicated falciparum malaria. Clin Infect Dis (2002) 3.40
Nested PCR analysis of Plasmodium parasites. Methods Mol Med (2002) 3.19
Clinical and laboratory features of human Plasmodium knowlesi infection. Clin Infect Dis (2009) 2.92
Plasmodium falciparum merozoite surface protein 3 is a target of allele-specific immunity and alleles are maintained by natural selection. J Infect Dis (2006) 2.75
Quantitative detection of Plasmodium falciparum DNA in saliva, blood, and urine. J Infect Dis (2009) 2.64
Risk factors for house-entry by malaria vectors in a rural town and satellite villages in The Gambia. Malar J (2008) 2.51
Common infections in diabetes: pathogenesis, management and relationship to glycaemic control. Diabetes Metab Res Rev (2007) 2.50
Continued decline of malaria in The Gambia with implications for elimination. PLoS One (2010) 2.47
Plasmodium knowlesi: reservoir hosts and tracking the emergence in humans and macaques. PLoS Pathog (2011) 2.45
IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life. Malar J (2007) 2.30
Isolation of viable Plasmodium falciparum merozoites to define erythrocyte invasion events and advance vaccine and drug development. Proc Natl Acad Sci U S A (2010) 2.25
Profiling the antibody immune response against blood stage malaria vaccine candidates. Clin Chem (2007) 2.23
Comparison of three antigen detection methods for diagnosis and therapeutic monitoring of malaria: a field study from southern Vietnam. Trop Med Int Health (2002) 2.22
Serum alanine aminotransferase, metabolic syndrome, and cardiovascular disease in an Australian population. Am J Gastroenterol (2009) 2.20
Swedish traveller with Plasmodium knowlesi malaria after visiting Malaysian Borneo. Malar J (2009) 2.18
Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specific. Infect Immun (2008) 2.18
Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care (2004) 2.09
Is self-monitoring of blood glucose appropriate for all type 2 diabetic patients? The Fremantle Diabetes Study. Diabetes Care (2006) 2.09
Platelet glycoprotein IIb/IIIa inhibition using eptifibatide with primary coronary stenting for acute myocardial infarction: a 30-day follow-up study. Catheter Cardiovasc Interv (2002) 2.07
Effects of a high-fat meal on the relative oral bioavailability of piperaquine. Antimicrob Agents Chemother (2005) 2.00
Morphological features and differential counts of Plasmodium knowlesi parasites in naturally acquired human infections. Malar J (2009) 1.97
High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya. Vaccine (2005) 1.89
Erythrocyte invasion phenotypes of Plasmodium falciparum in The Gambia. Infect Immun (2003) 1.85
Re-emergence of Chikungunya virus in South-east Asia: virological evidence from Sri Lanka and Singapore. J Gen Virol (2009) 1.85
Safety evaluation of fixed combination piperaquine plus dihydroartemisinin (Artekin) in Cambodian children and adults with malaria. Br J Clin Pharmacol (2004) 1.84
Allele frequency-based analyses robustly map sequence sites under balancing selection in a malaria vaccine candidate antigen. Genetics (2003) 1.82
Distinct roles for FOXP3 and FOXP3 CD4 T cells in regulating cellular immunity to uncomplicated and severe Plasmodium falciparum malaria. PLoS Pathog (2009) 1.81
Serum IgG3 to the Plasmodium falciparum merozoite surface protein 2 is strongly associated with a reduced prospective risk of malaria. Parasite Immunol (2003) 1.77
Anopheles gambiae complex along The Gambia river, with particular reference to the molecular forms of An. gambiae s.s. Malar J (2008) 1.76
A decline in the incidence of invasive non-typhoidal Salmonella infection in The Gambia temporally associated with a decline in malaria infection. PLoS One (2010) 1.72
Severe malaria - a case of fatal Plasmodium knowlesi infection with post-mortem findings: a case report. Malar J (2010) 1.72
Glucuronidation of dihydroartemisinin in vivo and by human liver microsomes and expressed UDP-glucuronosyltransferases. Drug Metab Dispos (2002) 1.70
Increasing incidence of Plasmodium knowlesi malaria following control of P. falciparum and P. vivax Malaria in Sabah, Malaysia. PLoS Negl Trop Dis (2013) 1.68
Genetic structure of Plasmodium falciparum populations in the Brazilian Amazon region. J Infect Dis (2004) 1.68
Evidence for diversifying selection on erythrocyte-binding antigens of Plasmodium falciparum and P. vivax. Genetics (2003) 1.67
A sub-microscopic gametocyte reservoir can sustain malaria transmission. PLoS One (2011) 1.67
Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations in Australian patients with type 2 diabetes from the Fremantle Diabetes Study. Med J Aust (2009) 1.67
RTS,S/AS02A malaria vaccine does not induce parasite CSP T cell epitope selection and reduces multiplicity of infection. PLoS Clin Trials (2006) 1.65
Pharmacokinetics and efficacy of piperaquine and chloroquine in Melanesian children with uncomplicated malaria. Antimicrob Agents Chemother (2007) 1.64
Comparison of surveillance methods applied to a situation of low malaria prevalence at rural sites in The Gambia and Guinea Bissau. Malar J (2009) 1.63
Two strategies for the delivery of IPTc in an area of seasonal malaria transmission in the Gambia: a randomised controlled trial. PLoS Med (2011) 1.61
Bionomics of Anopheles latens in Kapit, Sarawak, Malaysian Borneo in relation to the transmission of zoonotic simian malaria parasite Plasmodium knowlesi. Malar J (2008) 1.61
Antibodies to the N-terminal block 2 of Plasmodium falciparum merozoite surface protein 1 are associated with protection against clinical malaria. Infect Immun (2004) 1.60
A TaqMan real-time PCR assay for the detection and quantitation of Plasmodium knowlesi. Malar J (2010) 1.57
Features and prognosis of severe malaria caused by Plasmodium falciparum, Plasmodium vivax and mixed Plasmodium species in Papua New Guinean children. PLoS One (2011) 1.55
Population genomic scan for candidate signatures of balancing selection to guide antigen characterization in malaria parasites. PLoS Genet (2012) 1.55
Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine. Am J Trop Med Hyg (2014) 1.51
The pharmacokinetic properties of intramuscular artesunate and rectal dihydroartemisinin in uncomplicated falciparum malaria. Br J Clin Pharmacol (2002) 1.48
Three-Month Real-Time Dengue Forecast Models: An Early Warning System for Outbreak Alerts and Policy Decision Support in Singapore. Environ Health Perspect (2015) 1.46
Protective efficacy of the RTS,S/AS02 Plasmodium falciparum malaria vaccine is not strain specific. Am J Trop Med Hyg (2003) 1.45
Population genetic structure of Plasmodium falciparum across a region of diverse endemicity in West Africa. Malar J (2012) 1.44
Plasmodium knowlesi from archival blood films: further evidence that human infections are widely distributed and not newly emergent in Malaysian Borneo. Int J Parasitol (2009) 1.43
Fragmented population structure of plasmodium falciparum in a region of declining endemicity. J Infect Dis (2005) 1.42
Serum carboxymethyllysine concentrations are reduced in diabetic men with abdominal aortic aneurysms: Health In Men Study. J Vasc Surg (2009) 1.41
Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care (2005) 1.41
Peripheral arterial disease and risk of cardiac death in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care (2006) 1.40
Differential evidence of natural selection on two leading sporozoite stage malaria vaccine candidate antigens. Int J Parasitol (2006) 1.40
Variations in the configuration of the circle of Willis. Anat Sci Int (2008) 1.40
AV block. Which type and where? J Electrocardiol (2007) 1.39
Clinico-genetic characterisation of an encephalitic Dengue virus 4 associated with multi-organ involvement. J Clin Virol (2013) 1.38
Allele frequency-based and polymorphism-versus-divergence indices of balancing selection in a new filtered set of polymorphic genes in Plasmodium falciparum. Mol Biol Evol (2010) 1.38
Repeat sequences in block 2 of Plasmodium falciparum merozoite surface protein 1 are targets of antibodies associated with protection from malaria. Infect Immun (2003) 1.37
Natural selection on the erythrocyte surface. Mol Biol Evol (2002) 1.37
The current status and potential role of laboratory testing to prevent transfusion-transmitted malaria. Transfus Med Rev (2005) 1.36
Induction of strain-transcending antibodies against Group A PfEMP1 surface antigens from virulent malaria parasites. PLoS Pathog (2012) 1.35
Statistical estimation of cell-cycle progression and lineage commitment in Plasmodium falciparum reveals a homogeneous pattern of transcription in ex vivo culture. Proc Natl Acad Sci U S A (2009) 1.35
Loss-of-function mutations in IGSF1 cause an X-linked syndrome of central hypothyroidism and testicular enlargement. Nat Genet (2012) 1.34
A comparison of the sensitivities of detection of Plasmodium falciparum gametocytes by magnetic fractionation, thick blood film microscopy, and RT-PCR. Malar J (2009) 1.32
Population pharmacokinetics of artemether, lumefantrine, and their respective metabolites in Papua New Guinean children with uncomplicated malaria. Antimicrob Agents Chemother (2011) 1.32
Detecting signatures of balancing selection to identify targets of anti-parasite immunity. Trends Parasitol (2010) 1.31
Measurement of piperaquine in plasma by liquid chromatography with ultraviolet absorbance detection. J Chromatogr B Analyt Technol Biomed Life Sci (2003) 1.30
Clinical and parasitological response to oral chloroquine and primaquine in uncomplicated human Plasmodium knowlesi infections. Malar J (2010) 1.29
Is mosquito larval source management appropriate for reducing malaria in areas of extensive flooding in The Gambia? A cross-over intervention trial. Am J Trop Med Hyg (2010) 1.29
The "far-west" of Anopheles gambiae molecular forms. PLoS One (2011) 1.28
Haemoglobin C and S role in acquired immunity against Plasmodium falciparum malaria. PLoS One (2007) 1.28
Diabetes education and knowledge in patients with type 2 diabetes from the community: the Fremantle Diabetes Study. J Diabetes Complications (2003) 1.27